TransMedics Group (NASDAQ:TMDX) Now Covered by Piper Sandler

Research analysts at Piper Sandler started coverage on shares of TransMedics Group (NASDAQ:TMDX – Get Free Report) in a research report issued on Thursday, Marketbeat.com reports. The brokerage set an “overweight” rating and a $95.00 price target on the stock. Piper Sandler’s target price would suggest a potential upside of 28.48% from the stock’s previous […]

Leave a Reply

Your email address will not be published.

Previous post TC Bancshares (TCBC) vs. Its Competitors Financial Survey
Next post Baytex Energy Corp. (TSE:BTE) Receives C$6.65 Consensus Price Target from Brokerages